Acasti Pharma reported CAD2.98M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acasti Pharma ACST:US C$ 2.98M 1.47M
Addus Homecare ADUS:US $ 45.28M 2.09M
Agile Therapeutics AGRX:US $ 12.76M 3.07M
Amarin AMRN:US 102.96M 4.24M
Bioscrip BIOS:US $ 134.63M 376K
Genetic Technologies GENE:US $ 2.06M 1.16M
Pain Therapeutics PTIE:US $ 1.71M 475K